A
Anders Berglund
Researcher at University of South Florida
Publications - 147
Citations - 6314
Anders Berglund is an academic researcher from University of South Florida. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 29, co-authored 110 publications receiving 4853 citations. Previous affiliations of Anders Berglund include Pfizer & Moffitt Cancer Center.
Papers
More filters
Journal ArticleDOI
Radiomics: the process and the challenges
Virendra Kumar,Yuhua Gu,Satrajit Basu,Anders Berglund,Steven A. Eschrich,Matthew B. Schabath,Kenneth M. Forster,Hugo J.W.L. Aerts,Hugo J.W.L. Aerts,Andre Dekker,David Fenstermacher,Dmitry B. Goldgof,Lawrence O. Hall,Philippe Lambin,Yoganand Balagurunathan,Robert A. Gatenby,Robert J. Gillies +16 more
TL;DR: "Radiomics" refers to the extraction and analysis of large amounts of advanced quantitative imaging features with high throughput from medical images obtained with computed tomography, positron emission tomography or magnetic resonance imaging, leading to a very large potential subject pool.
Journal ArticleDOI
Some recent developments in PLS modeling
TL;DR: The original chemometrics partial least squares (PLS) model with two blocks of variables linearly related to each other, has had several enhancements/extensions since the beginning of 19...
Journal ArticleDOI
A high-resolution transcript profile across the wood-forming meristem of poplar identifies potential regulators of cambial stem cell identity.
Jarmo Schrader,Jeanette Nilsson,Ewa J. Mellerowicz,Anders Berglund,Peter Nilsson,Magnus Hertzberg,Göran Sandberg +6 more
TL;DR: Based on transcriptional and anatomical data, a model for the position of the stem cells and the proliferating mother cells in the cambial zone is presented and analysis of known regulators of apical meristem development indicates substantial similarity in regulatory networks between primary and secondary meristems.
Journal ArticleDOI
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
Jacob G. Scott,Anders Berglund,Michael J. Schell,Ivaylo B. Mihaylov,William J. Fulp,Binglin Yue,Eric A. Welsh,Jimmy J. Caudell,Kamran Ahmed,Tobin S Strom,Eric A. Mellon,Puja Venkat,Peter A.S. Johnstone,John A. Foekens,Jae K. Lee,Eduardo G. Moros,William S. Dalton,Steven A. Eschrich,Howard McLeod,Louis B. Harrison,Javier F. Torres-Roca +20 more
TL;DR: A GARD-based clinical model could allow the individualisation of radiotherapy dose to tumour radiosensitivity and could provide a framework to design genomically-guided clinical trials in radiation oncology.
Journal ArticleDOI
12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?
Jane L. Messina,David Fenstermacher,Steven A. Eschrich,Xiaotao Qu,Anders Berglund,Mark C. Lloyd,Michael J. Schell,Vernon K. Sondak,Jeffrey S. Weber,James J. Mulé +9 more
TL;DR: The 12-chemokine GES predicted the presence of unique, lymph node-like structures, containing CD20+ B cell follicles with prominent areas of CD3+ T cells, which was associated with better overall survival of the subset of melanoma patients.